• SENSEX 83,432.89
    193.42 (+0.23%)
  • BANKNIFTY 57,031.90
    239.95 (+0.42%)
  • Trent
    5,425.00 4,491.75(%)
  • HDB FINANC SER
    836.00 827.50(%)
  • J B Chemicals &
    1,630.00 1,303.00(%)
  • V-Guard Industri
    401.35 577.35(%)
  • PC Jeweller
    16.83 19.60(%)
  • C P C L
    781.00 1,274.00(%)
  • HDFC Bank
    2,004.25 2,027.40(%)
  • Bajaj Finance
    940.70 978.59(%)
  • Reliance Industr
    1,529.50 1,608.95(%)
  • CreditAcc. Gram.
    1,355.00 1,369.25(%)
  • Petronet LNG
    295.00 269.90(%)
  • Nippon ETF Liq.
    999.99 997.00(%)
  • Cochin Shipyard
    2,073.95 2,977.10(%)
  • Kotak Mah. Bank
    2,136.50 2,301.55(%)
  • TCS
    3,426.00 4,585.90(%)
  • Neetu Yoshi
    110.25 110.25(%)
  • Paras Defence
    933.50 971.80(%)
  • Nuvama Wealth
    7,202.25 4,567.80(%)
  • ICICI Bank
    1,444.00 1,471.10(%)
  • Tata Motors
    686.20 542.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Albert David Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 1254.0
  • ISIN : INE155C01010
946.55 57 (6.41%)
  • As on 06 Jul 2025 (EOD)
  • Today’s Low

    892.00
  • Today’s High

    953.50
  • Open

    909.00
  • Perv Close

    889.50
  • 52W Low

    762.60
  • 52W High

    1,753.95

Key Indicators

  • P/E(TTM)

    31.46

  • Mar.Cap (₹Cr.)

    540.48

  • Div & Yield %

    0.53

  • Book Value(₹)

    687.37

  • Debt-Equity Ratio

    6.41

  • AGM Date

    04-Jul-2025

  • EPS

    30.12

  • P/E Ratio

    31.46

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    540.48

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.71

  • BV (₹)

    687.40

  • Sales( ₹ in Cr.)

    345.77

  • NP (in Cr.)

    17.20

  • NP Var(%)

    -77.0

  • Div%

    50.0

  • CPS (₹)

    42.30

  • EPS (₹)

    30.10

  • Traded Value (₹ in Lakhs)

    541.11

  • 52 Week High

    1,753.95

  • 52 Week Low

    762.60

  • Price BSE

    948.0

  • Price NSE

    947.00

  • Market Capital( in Cr.)

    541.11

  • P/C Ratio

    22.40

  • P/E Ratio

    31.50

  • Price Vs.BV

    30.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 362.46 341.56 313.51 247.45 320.80 316.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 362.46 341.56 313.51 247.45 320.80 316.89
Other Income 57.55 15.40 15.84 17.18 7.11 15.70
Stock Adjustments 1.77 4.60 -2.38 -3.30 3.03 -1.25
Total Income 421.78 361.56 326.97 261.33 330.94 331.34
EXPENDITURE :            
Raw Materials 128.17 128.67 112.56 82.87 108.42 105.43
Power and Fuel Cost 16.42 18.85 13.22 8.52 13.83 12.77
Employee Cost 88.43 81.07 85.38 82.70 90.34 89.49
Other Manufacturing Expenses 8.04 7.17 7.14 6.68 7.56 8.04
Selling and Administration Expenses 63.45 55.69 44.15 37.09 59.68 61.13
Miscellaneous Expenses 12.74 10.25 7.75 7.01 13.48 8.88
Employee Benefit Expenses 88.43 81.07 85.38 82.70 90.34 89.49
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 317.24 301.69 270.20 224.87 293.32 285.73
Operating Profit 104.54 59.86 56.77 36.46 37.61 45.60
Interest 0.43 0.58 0.67 0.78 0.98 0.86
Gross Profit 104.11 59.28 56.10 35.68 36.63 44.74
Depreciation 6.83 8.55 8.81 8.23 7.67 6.98
Profit Before Tax 97.28 50.73 47.29 27.45 28.96 37.76
Current Tax 17.59 15.96 12.61 4.37 10.60 11.33
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.28 -1.40 -0.57 0.93 -0.81 -0.20
Reported Net Profit 75.42 36.17 35.26 22.14 19.17 26.64
Extraordinary Items 0.00 0.01 1.72 0.75 0.22 -0.27
Adjusted Net Profit 75.42 36.16 33.54 21.39 18.95 26.91
Adjustment below Net Profit 2.96 0.65 0.55 -0.25 -4.70 -0.75
P & L Balance brought forward 165.53 133.84 101.46 79.57 69.91 47.81
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 5.14 5.14 3.42 0.00 4.82 3.78
P & L Balance carried down 238.77 165.53 133.84 101.46 79.57 69.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 115.00 90.00 90.00 60.00 70.00 60.00
Dividend Per Share(Rs) 11.50 9.00 9.00 6.00 7.00 6.00
Earnings Per Share-Unit Curr 132.15 63.38 61.78 38.80 33.59 46.68
Earnings Per Share(Adj)-Unit Curr 132.15 63.38 61.78 38.80 33.59 46.68
Book Value 671.05 545.93 489.68 428.20 390.38 368.74
Book Value(Adj)-Unit Curr 671.05 545.93 489.68 428.20 390.38 368.74

Shareholding Pattern

  • Promoter Group

    62.24%

  • Public Share Holding

    37.76%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,854,431 50.01 2,854,431 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 697,527 12.22 697,527 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,551,958 62.24 3,551,958 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 700 0.01 0 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 57,511 1.01 57,511 11
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 91,850 1.61 91,850 1
Mutual Funds / UTI 800 0.01 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 570 0.01 570 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 151,431 2.65 149,931 16
2] Non Institution
Bodies Corporate 171,637 3.01 171,312 116
Clearing Members 19,470 0.34 19,470 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 51,467 0.90 51,467 283
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 105,021 1.84 105,019 484
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 100,256 1.76 100,256 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,464,969 25.67 1,425,127 14,367
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 250 0.00 250 1
Others 42,777 0.75 42,777 1
Sub Total 2,003,773 35.11 1,963,604 15,280
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,707,162 100.00 5,665,493 15,304

Company Background

Albert David LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Albert David Ltd
  • BSE Code : 1254.0
  • ISIN : INE155C01010
  • Incorporation Year

    1938

  • Registered Office

    D Block 3rd Flr Gillander Hous
    Netaji Subhas Road, Kolkata,
    West Bengal-700001

  • Telephone

    91-33-22302330/2262 8436/8456/

  • FAX

    91-33-22628439

  • Chairman

    A K Kothari

  • Managing Director

    U. M. Kunte

  • Company Secretary

  • Auditor

    L B Jha & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Maheshwari Datamatics Pvt Ltd
    23 RN Mukherjee Road,
    5th Floor ,
    Mumbai - Kolkata-700001

Albert David Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Albert David 947.65 420.01 362.46 31.46 26.86
Abbott India 34,746.45 6,097.18 5,848.91 52.20 44.71
Astrazeneca Phar 9,090.60 1,330.33 1,295.53 196.34 33.26
P & G Health Ltd 5,760.55 1,166.89 1,151.26 38.07 39.76
Glaxosmi. Pharma 3,285.70 3,866.05 3,723.49 60.57 58.72
Cipla 1,513.50 20,029.57 19,044.85 23.70 21.40
Amrutanjan Healt 712.85 437.58 421.23 40.55 20.84
Guj. Themis Bio. 350.45 174.19 169.82 78.23 44.82
Fermenta Biotec. 328.70 315.24 307.09 14.31 4.10
Bliss GVS Pharma 156.00 638.96 605.46 23.82 11.19
Ambalal Sarabhai 36.45 11.70 3.81 33.75 1.92